• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombus (2101)
Event Date 11/28/2016
Event Type  Injury  
Event Description
It was reported that the physician used the venaseal to treat the great saphenous vein in the right leg 5cm caudal of sfj.It was reported that instructions outlined within the ifu were followed with no issue noted.It was reported the patient had symptomatic pain in her right leg.An ultrasound approx.2 1/2 weeks post procedure showed 1.5cm thrombus in right common femoral vein.The patient was treated with eliquis 10mg and discharged.
 
Manufacturer Narrative
Investigation summary: an ultrasound exam report was provided.The report indicated a 10 mm to 13 mm of focus echogenic material extending from the greater saphenous vein into the patent common femoral vein.Per the exam report, there is no deep venous thrombosis and glue is present in the greater saphenous vein.The customer experience of the patent experience pain in the treated right leg was confirmed based on the provided ultra sound report.Thrombus or glue was extending from the greater saphenous vein into the common femoral vein.Md concluded no deep venous thrombosis and glue is present in the greater saphenous vein.The customer experience of thrombosis formation could not be positively confirmed.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560 6228
Manufacturer (Section G)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560 6228
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6185809
MDR Text Key62742404
Report Number2183870-2016-00732
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 03/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/30/2017
Device Model NumberVS-402
Device Lot Number42355
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/28/2016
Initial Date FDA Received12/19/2016
Supplement Dates Manufacturer ReceivedNot provided
03/27/2017
03/27/2017
Supplement Dates FDA Received04/25/2017
09/28/2017
10/02/2017
Date Device Manufactured10/08/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-